Pancreatic Cancer Research

ResearcherKindai University HospitalActive in the last 2 years

Kosuke Minaga

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5407-7925; OpenAlex author ID A5022208166. Sources: OpenAlex.

Their work

Papers
20 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
37
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: 2 papers · 2018: 3 papers · 2019: 2 papers · 2020: 1 paper · 2021: 2 papers · 2022: 2 papers · 2023: 2 papers · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper

Papers 20

  1. Comparison of Comprehensive Serum miRNA Sequencing and Apolipoprotein A2 Isoforms for Early Detection of Pancreatic Cancer. Co-author DOI 10.3390/cancers18071177↗
  2. Concealed pancreatic cancer in acute pancreatitis: Early MRCP and EUS surveillance improves prognosis and identifies high-risk patients. Co-author DOI 10.1016/j.pan.2025.02.013↗
  3. Early detection of pancreatic cancer by comprehensive serum miRNA sequencing with automated machine learning. Co-author DOI 10.1038/s41416-024-02794-5↗
  4. Early diagnosis of pancreatic cancer via pancreatic juice cytology with a cell-block method in a patient with altered anatomy First author DOI 10.1055/a-2317-0520↗
  5. Low-dose gemcitabine plus nab-paclitaxel versus standard-dose gemcitabine plus nab-paclitaxel in elderly patients with metastatic pancreatic cancer: A randomiz… Co-author DOI 10.1002/jgh3.12966↗
  6. Impact of Smad4 and p53 mutations on the prognosis of patients with pancreatic ductal adenocarcinoma undergoing chemotherapy. Co-author DOI 10.1007/s10147-023-02396-w↗
  7. Efficacy of EUS-guided celiac plexus neurolysis in combination with EUS-guided celiac ganglia neurolysis for pancreatic cancer-associated pain: a multicenter p… Co-author DOI 10.1007/s10147-022-02160-6↗
  8. Utility of contrast-enhanced harmonic EUS for diagnosis of portal vein invasion by pancreatic cancer. Co-author DOI 10.4103/eus-d-21-00185↗
  9. Improved detection of liver metastasis using Kupffer-phase imaging in contrast-enhanced harmonic EUS in patients with pancreatic cancer (with video). Co-author DOI 10.1016/j.gie.2020.06.051↗
  10. Analysis of Progression Time in Pancreatic Cancer including Carcinoma In Situ Based on Magnetic Resonance Cholangiopancreatography Findings. Co-author DOI 10.3390/diagnostics11101858↗
  11. Partial Pancreatic Parenchymal Atrophy Is a New Specific Finding to Diagnose Small Pancreatic Cancer (≤10 mm) Including Carcinoma in Situ: Comparison with Loca… Co-author DOI 10.3390/diagnostics10070445↗
  12. Contrast-enhanced harmonic endoscopic ultrasonography for evaluating the response to chemotherapy in pancreatic cancer. Co-author DOI 10.1016/j.dld.2019.03.015↗
  13. Clinical Safety and Efficacy of Secondary Prophylactic Pegylated G-CSF in Advanced Pancreatic Cancer Patients Treated with mFOLFIRINOX: A Single-center Retrosp… Co-author DOI 10.2169/internalmedicine.2234-18↗
  14. Impact of avascular areas, as measured by contrast-enhanced harmonic EUS, on the accuracy of FNA for pancreatic adenocarcinoma. Co-author DOI 10.1016/j.gie.2017.05.052↗
  15. Outcomes of endoscopic biliary drainage in pancreatic cancer patients with an indwelling gastroduodenal stent: a multicenter cohort study in West Japan. Co-author DOI 10.1016/j.gie.2018.01.021↗
  16. Alleviating Pancreatic Cancer-Associated Pain Using Endoscopic Ultrasound-Guided Neurolysis. Co-author DOI 10.3390/cancers10020050↗
  17. Association between the Risk Factors for Pancreatic Ductal Adenocarcinoma and Those for Malignant Intraductal Papillary Mucinous Neoplasm. Co-author DOI 10.1159/000481234↗
  18. EUS-Guided Pancreatic Duct Drainage for Repeat Pancreatitis in a Patient with Pancreatic Cancer. Co-author DOI 10.1159/000481238↗
  19. Predictors of pain response in patients undergoing endoscopic ultrasound-guided neurolysis for abdominal pain caused by pancreatic cancer. Co-author DOI 10.1177/1756283x16644248↗
  20. Surgically resected needle tract seeding following endoscopic ultrasound-guided fine-needle aspiration in pancreatic cancer. Co-author DOI 10.1002/jhbp.269↗

Closest collaborators

The 25 strongest of 37 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Masatoshi Kudo · 18 shared papers, 2016–2025 · strength 2.02
  2. Mamoru Takenaka · 16 shared papers, 2017–2025 · strength 1.83
  3. Kentaro Yamao · 15 shared papers, 2016–2025 · strength 1.66
  4. Ken Kamata · 15 shared papers, 2016–2025 · strength 1.57
  5. Masayuki Kitano · 8 shared papers, 2015–2023 · strength 0.75
  6. Atsushi Nakai · 8 shared papers, 2017–2023 · strength 0.74
  7. Yasuo Otsuka · 3 shared papers, 2022–2024 · strength 0.52
  8. Hidekazu Tanaka · 4 shared papers, 2019–2023 · strength 0.46
  9. Ippei Matsumoto · 5 shared papers, 2017–2022 · strength 0.45
  10. Yukitaka Yamashita · 4 shared papers, 2015–2024 · strength 0.42
  11. Munenori Kawai · 2 shared papers, 2024–2026 · strength 0.34
  12. Toshihiro Morita · 2 shared papers, 2024–2026 · strength 0.34
  13. Atsushi Umemura · 2 shared papers, 2024–2026 · strength 0.34
  14. Hiroshi Seno · 2 shared papers, 2024–2026 · strength 0.34
  15. Shujiro Yazumi · 2 shared papers, 2024–2026 · strength 0.34
  16. Akihisa Fukuda · 2 shared papers, 2024–2026 · strength 0.34
  17. Yoshifumi Takeyama · 4 shared papers, 2017–2022 · strength 0.33
  18. Masakatsu Tsurusaki · 3 shared papers, 2020–2021 · strength 0.32
  19. Tadashi Iida · 1 shared paper, 2025 · strength 0.22
  20. Takuya Ishikawa · 1 shared paper, 2025 · strength 0.22
  21. Yasuyuki Mizutani · 1 shared paper, 2025 · strength 0.22
  22. Yoshihisa Takada · 1 shared paper, 2025 · strength 0.22
  23. Kazuyuki Nagai · 1 shared paper, 2026 · strength 0.21
  24. Etsuro Hatano · 1 shared paper, 2026 · strength 0.21
  25. Hirotaka Kashima · 1 shared paper, 2026 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.